Campbell & Co Investment Adviser’s Aclaris Therapeutics ACRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-13,771	Closed	-$217K	–	743
2022 Q3	$217K	Buy	13,771 +294	+2%	+$4.63K	0.05%	594
2022 Q2	$188K	Buy	+13,477	New	+$188K	0.05%	614